Quantcast
Last updated on April 18, 2014 at 8:55 EDT

Latest Lilly Stories

2013-04-24 12:29:48

INDIANAPOLIS, April 24, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) has been named to the DiversityInc "Top 50 Companies for Diversity" list for the third consecutive year. DiversityInc's "Top 50 Companies for Diversity" is known as a leading assessment of diversity management globally. To make the list, participating companies must have more than 1,000 employees and demonstrate strength in key diversity areas: CEO commitment, human capital, corporate and organizational...

2013-04-24 08:28:19

INDIANAPOLIS, April 24, 2013 /PRNewswire/ -- Worldwide revenue was flat as growth in key products offset lower Zyprexa revenue following patent expirations. Cymbalta revenue increased 19 percent while Cialis increased 11 percent. Expense controls resulted in lower SG&A, offsetting growth in R&D expense. First quarter 2013 results include income of $495 million related to the transfer to Amylin of exenatide commercial rights outside of the U.S. Tax rate comparisons...

2013-04-10 08:31:17

Diverse pipeline reflected in four molecules targeting key cancer pathways WASHINGTON, April 10, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) unveiled data from four key molecules that represent the next generation of its oncology pipeline at the American Association for Cancer Research (AACR) Annual Meeting held in Washington, D.C. from April 6-10. The data reflect Lilly's diverse oncology pipeline via molecules that target several pathways that are among the most common...

2013-04-09 08:27:18

Revlon Global Brand Ambassadors Halle Berry, Emma Stone & Olivia Wilde to Host 2013 Events In New York City on May 4th & Los Angeles on May 11th LOS ANGELES, April 9, 2013 /PRNewswire/ -- Revlon (NYSE: REV), The Entertainment Industry Foundation (EIF) and Lilly Tartikoff are proud to announce the 20(th) Anniversary of the EIF Revlon Run/Walk for Women. Revlon Brand Ambassadors Emma Stone and Olivia Wilde will host the 2013 event in New York on Saturday, May 4(th )and Halle...

2013-04-08 12:28:10

2013 Honorees to Share their Stories at Special Awards Ceremony on April 9 WASHINGTON, April 8, 2013 /PRNewswire-USNewswire/ -- The National Council for Community Behavioral Healthcare (National Council) and Eli Lilly and Company are proud to announce the 2013 honorees of the prestigious Reintegration and Welcome Back Awards. The Reintegration Awards honor the contributions of individuals who live with schizophrenia and bipolar disorder and battle tremendous odds, as well as those who...

2013-04-03 16:24:49

INDIANAPOLIS, April 3, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will announce its financial results for the first quarter of 2013 on Wednesday, April 24, 2013. Lilly will also conduct a conference call on that day with the investment community and media to further detail the company's financial performance. The conference call will be held from 9:00 a.m. to 10:00 a.m. EDT. Investors, media and the general public can access a live webcast of the conference call through a link...

2013-03-26 12:29:34

Marketing application for the sodium glucose co-transporter-2 inhibitor follows submission of New Drug Application to U.S. Food and Drug Administration RIDGEFIELD, Conn. and INDIANAPOLIS, March 26, 2013 /PRNewswire/ -- Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced the European Medicines Agency (EMA) has accepted for review a marketing authorization application (MAA) for the investigational sodium glucose co-transporter-2 (SGLT2) inhibitor empagliflozin*,...

2013-03-25 08:26:43

Marketing application for the sodium glucose co-transporter-2 inhibitor follows completion of Phase III registration trials RIDGEFIELD, Conn. and INDIANAPOLIS, March 25, 2013 /PRNewswire/ -- Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced that a New Drug Application (NDA) for the investigational sodium glucose co-transporter-2 (SGLT2) inhibitor empagliflozin* was recently submitted to the Food and Drug Administration (FDA) in the United States for the...

2013-03-05 08:29:06

INDIANAPOLIS, March 5, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will conduct a conference call for the media and investment community to provide a pipeline update for its diabetes business on Monday, June 24, 2013. The call, which is being held in conjunction with the 73(rd) American Diabetes Association Scientific Sessions, will include updates on Phase III data for empagliflozin, an investigational sodium glucose co-transporter-2 (SGLT2) inhibitor, and dulaglutide, an...

2013-02-20 08:28:35

INDIANAPOLIS, Feb. 20, 2013 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the Team Solutions and Solutions for Wellness program resources for individuals living with serious mental illnesses, such as bipolar disorder and schizophrenia, have been added to the Substance Abuse and Mental Health Services Administration's (SAMHSA) National Registry of Evidence-Based Programs and Practices (NREPP), an online registry of evidence-based interventions for the prevention and...